March 10, 2022

FDA: Fresenius Kabi recalls Sodium Acetate Injection, USP, 400 mEq/100 mL

By: Judy Mathias
Share

Editor's Note

The Food and Drug Administration on March 7 posted the recall by Fresenius Kabi USA (Lake Zurich, Illinois) of seven lots of its Sodium Acetate Injection, USP, 400 mEq/100 mL

The recall was initiated because of the presence of particulate matter found in reserve and/or stability sample vials.

The lot (Batch) numbers are: 6124193, 6124196, 6124226, 6124532, 6125333, 6125678, and 6126846. These lots were distributed between September 2020 and November 2021.

To date, no adverse event reports have been received for these recalled lots.

Read More >>

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
December 2022
Video Spotlight
Live chat by BoldChat